ADRIAN THACKER: Open Payments
NPI 1831548247 · DUFFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$538 in 41 payments from 7 companies in 2025. Trend: 2023 $168 · 2024 $374 · 2025 $538
Food & beverage: $538
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $178 |
| Indivior Inc. | 5 | $105 |
| Axsome Therapeutics, Inc. | 4 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Gilead Sciences, Inc. | 2 | $46 |
| Braeburn Inc. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
Products named: VRAYLAR, SUBLOCADE, Auvelity, CAPLYTA, BRIXADI, REXULTI, MAVYRET.
Industry payments across VA — which companies pay providers there.
